Precision Genome Engineering: From Discovery to Cures (V5)
January 1-5, 2028
| Location to be Determined
Alexis C. Komor, Nicole Gaudelli and Gerald Schwank
Saturday, January 1, 2028
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
| 8:00–8:10 AM |
Welcome Remarks (Joint) |
|
| 8:10–9:00 AM |
Keynote Address (Joint) |
|
| |
David R. Liu †, Broad Institute, HHMI, and Harvard University
Advances in Programmable Genome Editing Technologies |
|
| 9:00–11:15 AM |
Technological Frontiers of Precision Genome Engineering (Joint) |
|
| 9:00–11:15 AM |
Meet the Editors (Joint) |
|
| |
Prashant Mali †, University of California, San Diego
Genome and Cell Engineering with Circular RNAs |
|
| |
James Dahlman †, Georgia Tech / Emory Medical School
Targeted in vivo Genome Engineering with Designer Nanoparticles |
|
| |
Kristy Wood †, Intellia Therapeutics, Inc.
Development of in vivo CRISPR Medicines |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–1:00 PM |
Poster Setup |
|
| 11:15–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Emerging and Innovative Genome Editing Technologies |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Emerging Nucleic Acid–Modifying Systems |
|
| |
Samuel H Sternberg †, Columbia University
Bacterial Immune Systems and Their Biotechnological Potential |
|
| |
Rotem Sorek †, Weizmann Institute of Science
Large-Scale Discovery of Non-CRISPR Bacterial Defense Systems |
|
| |
Elizabeth Kellogg †, St. Jude Children's Research Hospital
Structural Insights into New Nucleic Acid Modifying Systems |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Clinical Frontiers of Precision Genome Engineering (Joint) |
|
| |
Kiran Musunuru †, University of Pennsylvania
Development of N=1 Clinical Trials |
|
| |
Amy R. Simon †, Beam Therapeutics
Base Editing Clinical Trial |
|
| |
Bill Lundberg †, CRISPR Therapeutics
Ex vivo/in vivo CRISPR-based Therapeutics |
|
| |
Laura Sepp-Lorenzino †, Intellia Therapeutics
Perspectives on the Future of Genome Editing |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Protein Engineering and Computational Impacts on Genome Engineering |
|
| |
Alexis C. Komor, University of California, San Diego
Expanding the Capabilities of Base Editing |
|
| |
Jin-Soo Kim †, Korea Advanced Institute for Science and Technology
Mitochondrial Genome Editing |
|
| |
Britt Adamson †, Princeton University
Improving Genome Engineering Technologies using Mechanistic Insight |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Somatic and Germline Genome Engineering |
|
| |
Speaker to be Announced
Genome Editing to Treat Cardiovascular Disease |
|
| |
Tippi MacKenzie †, University of California, San Francisco
In utero Genome Editing |
|
| |
Kathy K. Niakan †, University of Cambridge
Base Editing to Study Human Embryogenesis |
|
| |
Manda Arbab †, Harvard University and Broad Institute
Development of Therapeutic Strategies to Treat Neurological Diseases |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:10–12:10 PM |
Ethics Round Table Discussion: Responsible Translation of Precision Genome Editing |
|
| 12:10–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2 |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:15 PM |
Closing Session (Joint) |
|
| |
Punit P. Seth, Alnylam Pharmaceuticals
Alnylam Update |
|
| |
Gerald Schwank, University Zurich
Prime Editing for Inherited Metabolic Diseases |
|
| |
Waseem Qasim †, University in London
Genome-Edited T Cell Therapies for Blood Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:15–7:00 PM |
Closing Keynote Address (Joint) |
|
| |
John M. Maraganore †, City Therapeutics
Novel RNAi |
|
| 7:00–7:15 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
|
| 7:15–8:15 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
Wednesday, January 5, 2028
